Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bungarus caeruleus venom toxins are a complex mixture of proteins and peptides secreted by the Common Krait, a highly venomous elapid snake native to South Asia (WHO, 2021). The primary constituents are neurotoxins, including presynaptic beta-bungarotoxins with phospholipase A2 activity and postsynaptic three-finger toxins (UniProt, 2023). These toxins collectively disrupt neuromuscular transmission, leading to progressive muscle paralysis and potentially fatal respiratory failure (StatPearls, 2023). While not therapeutic targets in the traditional sense, they are the pathological targets for neutralization by polyvalent antivenoms (PubMed, 2022). Understanding these toxins is critical for managing envenomation, which often presents with minimal local symptoms but rapid systemic neurotoxicity (NIH, 2020). The presynaptic toxins are particularly dangerous as they cause irreversible damage to nerve terminals, making early treatment vital.
Antivenom antibodies bind to the venom proteins (toxins), forming complexes that are cleared from the circulation, thereby preventing the toxins from reaching their physiological targets like the nicotinic acetylcholine receptor or presynaptic membranes (StatPearls, 2023). Neostigmine acts as an acetylcholinesterase inhibitor to temporarily increase acetylcholine concentration at the neuromuscular junction, although its efficacy is limited against Krait venom due to the presynaptic nature of the toxins (PubMed, 2021).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bungarus caeruleus venom toxins.